Total Valuation
Panacea Life Sciences Holdings Inc has a market cap or net worth of $6.80M. The enterprise value is $855.36K.
Market Cap$6.80M
Enterprise Value$855.36K
Share Statistics
Panacea Life Sciences Holdings Inc has 67,990,910 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding67,990,910
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Panacea Life Sciences Holdings Inc’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -31.33%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-31.33%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee303.51K
Profits Per Employee-138.89K
Employee Count3
Asset Turnover0.16
Inventory Turnover0.65
Valuation Ratios
The current PE Ratio of Panacea Life Sciences Holdings Inc is ―. Panacea Life Sciences Holdings Inc’s PEG ratio is 0.09.
PE Ratio―
PS Ratio3.27
PB Ratio0.55
Price to Fair Value0.55
Price to FCF4.82
Price to Operating Cash Flow12.96
PEG Ratio0.09
Income Statement
In the last 12 months, Panacea Life Sciences Holdings Inc had revenue of 910.52K and earned -416.68K in profits. Earnings per share was >-0.01.
Revenue910.52K
Gross Profit-1.22M
Operating Income-1.75M
Pretax Income-416.68K
Net Income-416.68K
EBITDA18.19K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 459.02K and capital expenditures -6.00, giving a free cash flow of 459.01K billion.
Operating Cash Flow459.02K
Free Cash Flow459.01K
Free Cash Flow per Share<0.01
Dividends & Yields
Panacea Life Sciences Holdings Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.40
52-Week Price Change66.67%
50-Day Moving Average0.10
200-Day Moving Average0.06
Relative Strength Index (RSI)59.17
Average Volume (3m)2.61K
Important Dates
Panacea Life Sciences Holdings Inc upcoming earnings date is Nov 18, 2021, After Close (Confirmed).
Last Earnings DateNov 19, 2020
Next Earnings DateNov 18, 2021
Ex-Dividend Date―
Financial Position
Panacea Life Sciences Holdings Inc as a current ratio of 15.48, with Debt / Equity ratio of 16.98%
Current Ratio15.48
Quick Ratio0.19
Debt to Market Cap0.07
Net Debt to EBITDA9.53
Interest Coverage Ratio-1.82
Taxes
In the past 12 months, Panacea Life Sciences Holdings Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Panacea Life Sciences Holdings Inc EV to EBITDA ratio is 173.05, with an EV/FCF ratio of 5.10.
EV to Sales3.46
EV to EBITDA173.05
EV to Free Cash Flow5.10
EV to Operating Cash Flow5.10
Balance Sheet
Panacea Life Sciences Holdings Inc has $40.83K in cash and marketable securities with $186.69K in debt, giving a net cash position of -$145.87K billion.
Cash & Marketable Securities$40.83K
Total Debt$186.69K
Net Cash-$145.87K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share$0.09
Margins
Gross margin is -612.89%, with operating margin of -192.56%, and net profit margin of -45.76%.
Gross Margin-612.89%
Operating Margin-192.56%
Pretax Margin-45.76%
Net Profit Margin-45.76%
EBITDA Margin2.00%
EBIT Margin-192.56%
Analyst Forecast
The average price target for Panacea Life Sciences Holdings Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-90.18%
EPS Growth Forecast-168.05%